Durect Corp (DRRX)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

10260 BUBB RD CUPERTINO, CA 95014

Develops pharmaceutical systems based on proprietary drug delivery technology platforms: the SABER Delivery System, the TRANSDUR Delivery System, the ORADUR sustained release oral gel-cap technology, the DURIN Biodegradable Implant, the DUROS System, and MICRODUR Biodegradable Microparticulates.

Data based on most recent fiscal year report
Market Cap334.238 Million Shares Outstanding148.55 Million Avg Volume1.186 Million
1-Yr BETA vs S&P TR1.425 Current Ratio2.87 Quick Ratio2.67
View SEC Filings from DRRX instead.
Q3 2019 All Institutions Hedge Funds 1
To trade DRRX now:
Filers who had this stock in their top 10: 1 0 (0.0%)
13F Filers holding this stock: 74 14 (1.46%)
Aggregate 13F shares on 09/30/2019: 57.862 Million 25.557 Million
Aggregate 13F shares on 06/30/2019: 86.866 Million 25.794 Million
Percent change: -33.39% -0.92%
Funds creating new positions: 15 5
Funds Adding to an existing position: 19 4
Funds closing out their position: 11 2
Funds reducing their position: 19 3
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding DRRX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding DRRX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

CASEY MICHAEL D

0 2019-11-20 0

SAXE JON S

0 2019-10-21 7

SHEPARD JAY PRESIDENT AND CEO

  • Officer
  • Director
72,754 2019-10-07 0

LIU JEAN I GC/EVP, LEG AFFAIRS

  • Officer
70,688 2019-09-30 0

BLEICHROEDER LP

  • 10% Owner
26,476,546 2019-09-02 1

FIRST EAGLE INVESTMENT MANAGEMENT, LLC

FIRST EAGLE HOLDINGS, INC.

  • 10% Owner
0 2019-09-01 1

FARFEL GAIL M EVP/CHIEF DEVELOPMENT OFFICER

  • Officer
4,891 2019-08-22 2

FIRST EAGLE INVESTMENT MANAGEMENT, LLC

21 APRIL FUND, L.P.

21 APRIL FUND, LTD.

FIRST EAGLE VALUE IN BIOTECHNOLOGY MASTER FUND, LTD.

FIRST EAGLE HOLDINGS, INC.

  • 10% Owner
26,476,546 2019-06-20 1

HOFFMANN DAVE

  • Director
0 2019-06-19 1

NEUKERMANS ARMAND

  • Director
0 2019-06-19 1

BLASCHKE TERRENCE F

  • Director
0 2019-06-19 1

BENITO SIMON X

  • Director
0 2019-06-19 1

ROBERTSON JUDITH J.

  • Director
0 2019-04-23 2

ARENBERG MICHAEL CHIEF FINANCIAL OFFICER

  • Officer
24,426 2019-03-12 2

BROWN JAMES E PRESIDENT & CEO

  • Officer
  • Director
0 2019-01-23 1

JOICE JUDY R SR. VP OPERATIONS & CORP QA

  • Officer
0 2019-01-23 1

STAUFFER JOSEPH WILLIAM CHIEF MEDICAL OFFICER

  • Officer
2,000 2018-10-17 0

THEEUWES FELIX CHAIRMAN AND CSO

  • Officer
  • Director
0 2018-01-26 0

HOGAN MATTHEW J CHIEF FINANCIAL OFFICER

  • Officer
0 2018-01-26 0

21 APRIL FUND, LTD.

21 APRIL FUND, L.P.

FIRST EAGLE VALUE IN BIOTECHNOLOGY MASTER FUND, LTD.

FIRST EAGLE HOLDINGS, INC.

  • 10% Owner
22,381,546 2016-09-26 0

YUM SU IL EXEC. VP PHARM./R&D

  • Officer
0 2015-01-09 0

LANGECKER PETER CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
77,993 2013-08-08 0

MENDENHALL PAULA V EXEC. VP OF OPERATIONS/ADMIN.

  • Officer
0 2012-02-03 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5
No current insider transactions
Click here to report any possible errors with this stock listing.

Elevate your investments